Ex Parte Van Den Berg et alDownload PDFPatent Trial and Appeal BoardAug 22, 201612308355 (P.T.A.B. Aug. 22, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/308,355 07/23/2010 4743 7590 08/24/2016 MARSHALL, GERSTEIN & BORUN LLP 233 SOUTH WACKER DRIVE 6300 WILLIS TOWER CHICAGO, IL 60606-6357 FIRST NAMED INVENTOR Keimpe Jan Van Den Berg UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. C0/2-23920/Z/AKZ l/PCT 4407 EXAMINER LIGHTFOOT, ELENA TSOY ART UNIT PAPER NUMBER 1715 NOTIFICATION DATE DELIVERY MODE 08/24/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): mgbdocket@marshallip.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte KEIMPE JAN VAN DEN BERG, JOSEPHUS CHRISTIAAN VAN OORSCHOT, EDITH BENNINGSHOF-HULSBOS, and JAN CORNELIS VAN BEELEN Appeal2014-007094 Application 12/308,355 1 Technology Center 1700 Before CHUNG K. PAK, PETER F. KRATZ, and JEFFREY T. SMITH, Administrative Patent Judges. SMITH, Administrative Patent Judge. DECISION ON APPEAL This is a decision on appeal under 35 U.S.C. § 134 from the Examiner's final rejection of claims 1, 8, and 16-22. We have jurisdiction pursuant to 35 U.S.C. § 6(b ). We AFFIRM. 1 According to the Appeal Brief, the Real Party in Interest is CIBA Corporation. (App. Br. 3.) Appeal2014-007094 Application 12/308,355 BACKGROUND According to Appellants, the invention is directed to "an actinic radiation-curable coating composition comprising a compound having at least two isocyanate groups, a compound having at least two hydroxyl groups, and a photolatent catalyst for the isocyanate-hydroxyl addition reaction." (Spec. 1 ). Claim 1 is reproduced below from the Claims Appendix to the principal Brief: 1. An actinic radiation-curable coating composition compnsmg a compound having at least two isocyanate groups, a compound having at least two hydroxyl groups, a sensitizer, and a photolatent catalyst for the isocyanate-hydroxyl addition reaction, wherein the photolatent catalyst is an organic metal compound compnsmg a catalytically active metal, wherein the catalytically active metal atom in the organic metal compound has no bonds to other metal atoms, and wherein the photolatent catalyst is dibutyl dibenzyl tin, dibutyl di-(3-methoxybenzyl)tin, or dibutyl di-(naphthalene-1-yl- methyl)tin. The Examiner maintains, and Appellants appeal, the rejection of claims 1, 8, and 16-22 under 35 U.S.C. § 103(a) as unpatentable over Klinkenberg (U.S. Patent No. 6,579,913, issued Jun. 17, 2003) in view of Gerkin (U.S. Patent Application Publication No. 2003/0199663, published 2 Appeal2014-007094 Application 12/308,355 Oct. 23, 2003) and Goldstein (U.S. Patent No. 5,850,064, issued Dec. 15, 1998).2 ANALYSIS Appellants argue the Klinkenberg describes the advantages of compositions comprising photolatent base belonging to the group of a- amino acetophenones and does not teach or suggest a photolatent tin catalyst as required by claim 1. (App. Br. 8). Appellants argue the Examiner has not adequately explained why a person of ordinary skill in the art would replace Klinkenberg's optional tin catalyst with a very specific photolatent tin catalyst. (App. Br. 9). The Examiner found3 Klinkenberg describes photoactivatable coatings comprising photolatent catalyst. (Final Act. 4). Klinkenberg discloses the photo activatable coatings comprise a photolatent base and optionally-if hydroxyl functional compounds are present- an additional tin catalyst. (Klinkenberg, col. 1, 11. 45-59, col. 8, 11. 18-22). The Examiner recognized Klinkenberg' s tin catalyst was not described as a photo latent catalyst. (Final Act. 4). The Examiner found the pot life of Klinkenberg's coating composition was greater than one day. (Final Act. 4). The Examiner found Gerkin described dibutyl dibenzyl tin catalyst that are latent catalyst for the isocyanate-hydroxyl addition reaction. (Final Act. 4; Gerkin ,-i,-i 39--42, 45). The Examiner cited Goldberg for describing tin catalyst were known to be 2 The Examiner withdrew the rejection of claims 1, 8, and 16-20 over Klinkenberg, Zemlin and Goldstein. (Ans. 4). 3 A complete statement of the Examiner's findings appear in the Final Action dated June 17, 2013. 3 Appeal2014-007094 Application 12/308,355 heat or UV activatable. (Final Act. 5). The Examiner determined that it would have been obvious to a person of ordinary skill in the art to use a latent dibutyl dibenzyl tin catalyst as tin based catalyst in Klinkenberg for the isocyanate-hydroxyl reaction- with the expectation of achieving the required pot life required by Klinkenberg. (Final Act. 5). Appellants' arguments are not persuasive of reversible error in the Examiner's rejection. It is not been disputed that Klinkenberg discloses photoactivatable compositions comprising optionally utilizing a tin based catalyst reaction for hydroxyl groups. The Examiner found Gerkin describes latent dibutyl dibenzyl tin catalyst that would achieve Klinkenberg's pot life requirements. As such, the Examiner reasonably determined that it would have been obvious to a person of ordinary skill in the art to utilize a dibutyl dibenzyl tin catalyst Klinkenberg's coating composition. The "comprising" claim language does not preclude the use of more than one catalyst. Klinkenberg describes the situation in which is desirable to utilize tin catalyst. Klinkenberg disclosure in col. 8 does not provide an exclusive list of suitable catalysts. The Examiner has properly identified dibutyl dibenzyl tin catalyst was a known catalyst for reacting with hydroxyl groups. Consequently, a person of ordinary skill in the art would have reasonably expected that a dibutyl dibenzyl tin catalyst would have been suitable for use in Klinkenberg. When evidence of secondary considerations is submitted, we begin anew and evaluate the rebuttal evidence along with the evidence upon which the conclusion of prima facie obviousness was based. In re Rinehart, 531 F.2d 1048, 1052 (CCPA 1976). Appellants argue that the data presented in Tables 3--4 of the Specification demonstrate that the claimed coating 4 Appeal2014-007094 Application 12/308,355 compositions exhibit long gel time and indicates the compositions have a long pot life. (App. Br. 18). The Examiner asserts the evidence presented in the specification describes expected results in view of the teachings of Gerkin. (Answer 5-6). The coating compositions of Klinkenberg exhibit long pot life and Gerkin describes latent dibutyl dibenzyl tin catalyst have a long pot life. (Klinkenberg, col. 8; Gerkin iJ80). In view of the disclosure of Klinkenberg and Gerkin, Appellants have not demonstrated the data presented in the Specification exhibits unexpected results. Therefore, on this record, we find no reversible error in the Examiner's determination that the evidence of obviousness, on balance, outweighs the evidence of non-obviousness relied upon by Appellants, and we accordingly sustain the Examiner's rejection of claims 1, 8 and 16-22 under 35 U.S.C. § 103(a) as unpatentable over Klinkenberg, Gerkin, and Goldberg. ORDER For the reasons set forth above and in the Answer, the decision of the Examiner is affirmed. TIME PERIOD No time period for taking any subsequent action in connection withthis appeal may be extended under 37 C.F.R. § l.136(a)(l). AFFIRMED 5 Copy with citationCopy as parenthetical citation